Kevin Michael Donahue serves as Executive at MAINZ BIOMED N.V., where they oversee executive responsibilities. Since joining the company, Kevin Michael Donahue has executed 1 insider transactions totaling $258.8B, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 17, 2025 involved purchasing 643,850 shares valued at $258.8B.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 17, 2025 | MYNZ | $258.8B | Purchase | 643,850 | $402000.00 | Discretionary |
Kevin Michael Donahue currently holds 643,850 shares of MAINZ BIOMED N.V. (MYNZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Michael Donahue has been a net buyer of MYNZ stock. They have purchased $258.8B and sold $0 worth of shares.
Kevin Michael Donahue's most recent insider trade was on Oct 17, 2025, when they purchased 643,850 shares at $402000.00 per share.
Get notified when new Form 4 filings are submitted